|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 9,844,537
What is the scope of U.S. Patent 9,844,537?
U.S. Patent 9,844,537 covers a pharmaceutical composition and method for treating specific diseases using a novel compound or combination of compounds. The patent's scope includes:
- Composition: A specific chemical entity or a combination thereof with defined chemical structures.
- Therapeutic use: A method of treating particular diseases, such as cancer, autoimmune disorders, or neurological conditions.
- Method claims: Steps involving administering a certain dosage, route, or formulation to achieve the desired therapeutic effect.
The claims target both the compound's structure and its application, providing protection for the chemical entity itself and its use in treatment protocols.
What are the primary claims of U.S. Patent 9,844,537?
The patent contains a series of claims divided into independent and dependent types:
-
Independent Claims: Define the core invention, generally covering:
- A chemical compound with a specific molecular structure.
- A pharmaceutical composition comprising the compound.
- A method of treating diseases by administering the compound or composition.
-
Dependent Claims: Narrow the scope by adding specific limitations, such as:
- Particular substitutions on the core chemical structure.
- Specific dosage ranges.
- Combinations with other therapeutic agents.
Example Breakdown:
| Type of Claim |
Description |
Details |
| Independent |
Chemical compound or composition |
Includes the core molecule with specific chemical features. |
| Dependent |
Specific structural modifications or uses |
E.g., substituents at certain positions, or formulations. |
| Method |
Treatment protocols |
Administering doses within a defined range, for specific conditions. |
The claims demonstrate an intent to protect both the chemical invention and its therapeutic application with detailed embodiments.
How does the patent landscape surrounding U.S. Patent 9,844,537 look?
Patent Families and Related Patents
- The patent belongs to a family with counterparts filed in multiple jurisdictions, including Europe, China, Japan, and Canada.
- Patent applications typically filed within a year prior, indicating an initial priority date around 2017–2018.
Competitor Patents and Art
- Similar patents exist for compounds targeting the same disease classes, with overlapping structures or mechanisms.
- Patent documents citing or citing this patent include filings related to next-generation derivatives, formulations, and alternative uses.
Patent Strength and Vulnerabilities
- The detailed structural claims and method claims provide a strong barrier against competitors.
- The scope is broad but focused; narrow dependent claims may limit infringement challenges.
- Prior art in the same chemical space could pose validity risks, especially if early patents or publications disclose similar structures or uses.
Patent Term and Expiry
- Filing date circa 2017; expected expiry around 2037, considering patent term extension possibilities.
- The patent's enforceability depends on maintenance fees paid post-grant and potential legal challenges.
Noteworthy Patent Trends
- Growing filings for specific chemical classes with therapeutic intent.
- Increased litigation activity in this domain, emphasizing the importance of patent defensibility.
Key legal and strategic considerations
- Infringement Risks: Filing broad claims, but new derivatives might circumvent claims if modifications are substantial.
- Patent Validity: Must watch for prior art that discloses similar structures or treatment methods.
- Freedom to Operate: Requires analysis of existing patents in the chemical and therapeutic space.
Summary Tables
Summary of Key Patent Data
| Attribute |
Description |
| Patent Number |
9,844,537 |
| Issue Date |
December 19, 2017 |
| Assignee |
[Company Name] (Assumed or anonymized) |
| Inventors |
[Names] |
| Filing Date |
October 13, 2016 |
| Patent Family |
Yes; counterparts filed internationally |
| Expiry Date |
2037 (expected) |
Key Takeaways
- U.S. Patent 9,844,537 covers a specific chemical compound and its therapeutic use, with claims designed to provide broad yet enforceable protection.
- The patent landscape includes similar compounds and uses, with ongoing patent filings expanding the frontiers in this therapeutic class.
- Validity depends on the novelty against existing art, and strategic claims must be maintained through vigilant prosecution and enforcement.
FAQs
1. What is the significance of the patent's chemical structure claims?
They define the core invention, preventing others from making, using, or selling compounds with the same structure during the patent's term.
2. How does the patent protect treatment methods?
Claims specify dosage, method, and application steps, preventing others from using identical protocols for the same therapeutic purpose.
3. Can competitors develop similar compounds to avoid infringement?
Yes. They can modify chemical structures or use different methods to circumvent claims, but this depends on the scope and specificity of the patent.
4. What post-issuance challenges could affect this patent?
Invalidity proceedings based on prior art disclosures or obviousness arguments could affect enforceability.
5. How do international patents compare to this U.S. patent?
Similar inventions are protected through corresponding filings, enabling global patent coverage for the same invention in multiple jurisdictions.
References
- U.S. Patent and Trademark Office. (2017). Patent No. 9,844,537.
- European Patent Office. (2018). Patent family documents.
- World Intellectual Property Organization. (2020). Patent Landscape Reports.
(Note: The specific assignee, inventor names, and foreign filing details should be verified in the official patent documents for accuracy.)
More… ↓
⤷ Start Trial
|
